Blood eosinophils predict therapeutic effects of a GATA3-specific DNAzyme in asthma patients

The effect of the GATA3-mRNA-specific DNAzyme SB010 treatment on EAR and LAR responses continuously increased with higher relative levels of blood eosinophils making them a suitable biomarker to stratify asthma patients for inhaled SB010 treatment.

http://ift.tt/2mul9Xq